tradingkey.logo

ReShape Lifesciences Inc

RSLS
Detailliertes Diagramm anzeigen
3.920USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
10.29MMarktkapitalisierung
VerlustKGV TTM

ReShape Lifesciences Inc

3.920
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Heute

0.00%

5 Tage

0.00%

1 Monat

0.00%

6 Monate

+51.94%

Seit Jahresbeginn

0.00%

1 Jahr

-94.90%

Detailliertes Diagramm anzeigen

TradingKey Aktien-Score

Kein Aktien-Score verfügbar aufgrund unzureichender Daten.

ReShape Lifesciences Inc Nachrichten

Bald gibt es mehr Neuigkeiten, bleiben Sie dran...

Finanzindikatoren

EPS

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Gesamteinnahmen

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

ReShape Lifesciences Inc Informationen

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
BörsenkürzelRSLS
UnternehmenReShape Lifesciences Inc
CEOMr. Paul F. Hickey
Websitehttps://www.reshapelifesciences.com/obalon/
KeyAI